secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K
Filed at:   2026-01-30T23:59:59+00:00
Accession:  0001493152-26-004543
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspire Biopharma raises $2M via 8% OID debentures with 790K incentive shares
----------------------------------------------------------------------------

- Issued $2,173,913 principal of 8% OID debentures for $2,000,000; maturity sooner of 90 days or $8M financing event.
- Debentures are non-convertible, bear no interest; 790,000 shares of common stock issued as incentive shares.
- Proceeds to be used for debt repayment and working capital; offering exempt under Section 4(a)(2).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000149315226004543/0001493152-26-004543-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000149315226004543/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-004543

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer